KERX: Keryx Biopharmaceuticals, Inc. Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
2001	10.125	7.30	-2.825	-27.90%
2002	7.30	1.58	-5.72	-78.36%
2003	1.58	4.65	3.07	194.30%
2004	4.65	11.57	6.92	148.82%
2005	11.57	14.64	3.07	26.53%
2006	14.64	13.30	-1.34	-9.15%
2007	13.30	8.40	-4.90	-36.84%
2008	8.40	0.22	-8.18	-97.38%
2009	0.22	2.50	2.28	1036.36%
2010	2.50	4.58	2.08	83.20%
2011	4.58	2.53	-2.05	-44.76%
2012	2.53	2.62	0.09	3.56%
2013	2.62	12.95	10.33	394.27%
2014	12.95	14.15	1.20	9.27%
2015	14.15	5.05	-9.10	-64.31%
2016	5.05	5.86	0.81	16.04%
2017	5.86	4.65	-1.21	-20.65%
2018	4.65	2.07*	-2.58	-55.48%

*In 2018, Keryx Biopharmaceuticals (KERX) merged with Akebia Therapeutics (AKBA). KER shareholders received .37433 shares of AKBA for every share of KERX held.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).